Modafinil Tablets are prescription medications used to promote wakefulness in individuals with excessive sleepiness caused by conditions such as narcolepsy, obstructive sleep apnea, and shift work sleep disorder. They help improve alertness, concentration, and reduce daytime fatigue, supporting better daily functioning.

The exact mechanism of modafinil is not fully understood, but it is believed to work by altering neurotransmitters in the brain, including dopamine, norepinephrine, and histamine. Modafinil enhances wakefulness by stimulating certain areas of the brain responsible for alertness and attention, without the strong stimulant effects seen with other drugs

Contraindications & Precautions
Caution should be exercised in patients with a history of heart problems, high blood pressure, liver or kidney disease, and psychiatric disorders such as anxiety, depression, or psychosis. It should not be used to treat general fatigue or as a substitute for adequate sleep.

Adverse Reactions / Side Effects
Less frequently, serious skin reactions such as Stevens-Johnson syndrome or allergic reactions may occur. Patients should seek immediate medical attention if they experience rash, swelling, or difficulty breathing.

Pregnancy & Breastfeeding
There is limited data on the safety of modafinil during pregnancy and breastfeeding. Therefore, it should be used during these periods only if the potential benefits outweigh the risks and under strict medical supervision. Alternative treatments with better-established safety profiles are often preferred

Store this medication at 68°F to 77°F (20°C to 25°C) and away from heat, moisture and light. Keep all medicine out of the reach of children. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain.

1. Broughton RJ, Fleming JA, George CF. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997;49:444-51.
2. Kingshott RN, Vennelle M, Coleman EL, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001
3. Provigil (modafinil) package insert. Frazer, PA: Cephalon; 2015 Jan.
4. Rammohan KW, Rosenberg JH, Lynn DJ, et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002;72:179-183.
5. Nieves AV, Lang AE. Treatment of excessive daytime sleepiness in patients with Parkinson’s disease with modafinil. Clin Neuropharmacol 2002;25:111-114.
6. DeBattista C, Doghramji K, Menza MA, et al; Modafinil in Depression Study Group. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry. 2003;64:1057-1064.
7. Fava M, Thase ME, DeBattista C, et al. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry 2005;66:85-93.
8. Turner DC, Clark L, Dowson J, et al. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2004;55:1031-1040.
9. Arnold VK, Feifel D, Earl CQ, et al. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. J Atten Disord. 2014;18:133-144. Epub 2012 May 22.
10. Kaplan S, Braverman DL, Frishman I, Bartov N. Pregnancy and fetal outcomes following exposure to modafinil and armodafinil during pregnancy. JAMA Intern Med 2020; Published online Oct. 19, 2020. doi:10.1001/jamainternmed.2020.4009.
11. Hackett LP, Kristensen JH, Hale TW, et al. Methylphenidate and breast-feeding. Ann Pharmacother 2006;40:1890-1.
12. Spigset O, Brede WR, Zahlsen K. Excretion of methylphenidate in breast milk. Am J Psychiatry 2007;164:348
13. American Academy of Pediatrics (AAP) Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108(3):776-789.
14. Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics 2005;116:777-84
15. Bachot N, Roujeau JC. Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol 2003;4:561-72